Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eric R. Xue"'
Autor:
Hangfei Fu, Yu Sun, Ying Shao, Jason Saredy, Ramon Cueto, Lu Liu, Charles Drummer, Candice Johnson, Keman Xu, Yifan Lu, Xinyuan Li, Shu Meng, Eric R. Xue, Judy Tan, Nirag C. Jhala, Daohai Yu, Yan Zhou, Kayla J. Bayless, Jun Yu, Thomas J. Rogers, Wenhui Hu, Nathaniel W. Snyder, Jianxin Sun, Xuebin Qin, Xiaohua Jiang, Hong Wang, Xiaofeng Yang
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Interleukin (IL) 35 is a novel immunosuppressive heterodimeric cytokine in IL-12 family. Whether and how IL-35 regulates ischemia-induced angiogenesis in peripheral artery diseases are unrevealed. To fill this important knowledge gap, we used loss-of
Externí odkaz:
https://doaj.org/article/df5786bc9d924b9887e995d716859508
Autor:
Hangfei Fu, Nish Vadalia, Eric R. Xue, Candice Johnson, Luqiao Wang, William Y. Yang, Claudette Sanchez, Jun Nelson, Qian Chen, Eric T. Choi, Jian-Xing Ma, Jun Yu, Hong Wang, Xiaofeng Yang
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-21 (2017)
Abstract Background Current angiogenic therapies for cancers and cardiovascular diseases have not yet achieved expected benefits, which reflects the need for improved understanding of angiogenesis. In this study, we focused on solving the problem of
Externí odkaz:
https://doaj.org/article/82acf15a6e2b4277874048672e752025
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Current angiogenic therapies for cancers and cardiovascular diseases have not yet achieved expected benefits, which reflects the need for improved understanding of angiogenesis. In this study, we focused on solving the problem of whether tissues have
Autor:
Nish Vadalia, Hangfei Fu, Jun Yu, Xiaofeng Yang, Luqiao Wang, Candice Johnson, Eric T. Choi, Claudette Sanchez, Hong Wang, Eric R. Xue, Qian Chen, Jun Nelson, William Y. Yang, Jian Xing Ma
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-21 (2017)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Current angiogenic therapies for cancers and cardiovascular diseases have not yet achieved expected benefits, which reflects the need for improved understanding of angiogenesis. In this study, we focused on solving the problem of whether t